calaspargase pegol

FDA Drug Profile — asparlas

Drug Details

Generic Name
calaspargase pegol
Brand Names
asparlas
Application Number
BLA761102
Sponsor
Servier Pharmaceuticals LLC
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
CALASPARGASE PEGOL

Indications and Usage

1 INDICATIONS AND USAGE ASPARLAS is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years. ( 1.1 ) 1.1 Acute Lymphoblastic Leukemia ASPARLAS is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years.